Cover
Cover | Aug. 12, 2024 |
Entity Addresses [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 12, 2024 |
Entity File Number | 001-37939 |
Entity Registrant Name | MARKER THERAPEUTICS, INC. |
Entity Central Index Key | 0001094038 |
Entity Tax Identification Number | 45-4497941 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2450 Holcombe Blvd |
Entity Address, Address Line Two | Suite BCM-A |
Entity Address, Address Line Three | MS: BCM251 |
Entity Address, City or Town | Houston |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77021 |
City Area Code | 713 |
Local Phone Number | 400-6400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | MRKR |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Former Address [Member] | |
Entity Addresses [Line Items] | |
Entity Address, Address Line One | 9350 Kirby Drive |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | Houston |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77054 |